شاهین آخوندزاده

سمتهای علمی و اجرایی در دانشگاهها و مراکز علمی کشور

عضو هیات علمی دانشگاه علوم پزشکی و خدمات بهداشتی درمانی تهران

سمتهای علمی و اجرایی در کنفرانس ها و نشستهای معتبر ایران

دبیر علمی اولین کنگره سبک زندگی سالم(1401)

مقالات بین المللی خارج از کشور

"Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial", Mary Ann Liebert Inc, (2018), Vol 24, No 4: 361-368
"<scp>l</scp>-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial", Mary Ann Liebert Inc, (2018), Vol 28, No 1: 74-81
"Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial", Mary Ann Liebert Inc, (2016), Vol 26, No 6: 513-519
"Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence", Ovid Technologies (Wolters Kluwer Health), (2018), Vol 33, No 2: 111-119
"A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder", Elsevier BV, (2009), Vol 168, No 3: 234-237
"Simvastatin adjunct therapy for negative symptoms of schizophrenia", Ovid Technologies (Wolters Kluwer Health), (2017), Vol 32, No 2: 87-94
"Published research on attention deficit hyperactivity disorder : a comparative analysis of medline and an Iranian bibliographic database", Wiley, (2010), Vol 27, No 2: 155-157
"Prevention of muscimol-induced long-term depression by brain-derived neurotrophic factor", Elsevier BV, (1999), Vol 23, No 7: 1215-1226
"Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam", Wiley, (2001), Vol 26, No 5: 363-367
"Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial", Wiley, (2001), Vol 26, No 5: 369-373
"Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial", Wiley, (2001), Vol 26, No 1: 67-71
"Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia*", Wiley, (2002), Vol 27, No 6: 453-459
"Potentiation of muscimol-induced long-term depression by benzodiazepines but not zolpidem", Elsevier BV, (2002), Vol 26, No 6: 1161-1166
"Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients", Ovid Technologies (Wolters Kluwer Health), (2016), Vol 31, No 1: 20-26
"Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial", BMJ, (2003), Vol 74, No 7: 863-866
"Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial", Springer Science and Business Media LLC, (2003), Vol 3, No 1:
"Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder", Elsevier BV, (2010), Vol 34, No 7: 1269-1272
"Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial", Elsevier BV, (2003), Vol 27, No 1: 123-127
"Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial", Wiley, (2003), Vol 28, No 1: 53-59
"Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial", Wiley, (2010), Vol , No : n/a-n/a
"Hydroxyzine may be safe and effective in generalised anxiety disorder", BMJ, (2003), Vol 6, No 3: 91-91
"Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial", Elsevier BV, (2003), Vol 27, No 5: 841-845
"Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial", Elsevier BV, (2003), Vol 27, No 6: 1007-1012
"Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial", SAGE Publications, (2013), Vol 28, No 7: 677-685
"Comparing the efficacy and safety ofCrocus sativusL. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial", Wiley, (2014), Vol 29, No 4: 351-359
"Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study", Wiley, (2012), Vol 27, No 4: 411-418
"A Double-Blind, Randomized, and Placebo-Controlled Trial of Buspirone Added to Risperidone in Patients With Chronic Schizophrenia", Ovid Technologies (Wolters Kluwer Health), (2010), Vol 30, No 6: 678-682
"Author's response to Yang R et al.: Several concerns arise when the results are interpreted", Wiley, (2011), Vol 26, No 1: 88-88
"Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder", Ovid Technologies (Wolters Kluwer Health), (2014), Vol 29, No 6: 344-350
"Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]", Springer Science and Business Media LLC, (2004), Vol 4, No 1:
"Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: A 17-year experience", Springer Science and Business Media LLC, (2004), Vol 4, No 1:
"Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial", Wiley, (2011), Vol 26, No 2: 120-124
"A comparative trial of Crocus sativus L. (saffron) and imipramine in mild to moderate depression", Wiley, (2010), Vol 10, No 1: 22-23
"Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial", Elsevier BV, (2005), Vol 29, No 2: 253-259
"Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trial", Elsevier BV, (2014), Vol 219, No 3: 431-435
"Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial", Springer Science and Business Media LLC, (2015), Vol 23, No 1:
"Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial", SAGE Publications, (2015), Vol 29, No 5: 575-581
"Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial", Elsevier BV, (2014), Vol 166, No : 201-205
"Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial", Springer Science and Business Media LLC, (2014), Vol 22, No 1:
"N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism", Ovid Technologies (Wolters Kluwer Health), (2015), Vol 38, No 1: 11-17
"Lipoid proteinosis: phenotypic heterogeneity in Iranian families with c.507delT mutation inECM1", Wiley, (2015), Vol 24, No 3: 220-222
"Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial", Springer Science and Business Media LLC, (2010), Vol 213, No 4: 809-815
"Health-related quality of life of Iranian children with attention deficit/hyperactivity disorder", Springer Science and Business Media LLC, (2010), Vol 20, No 1: 31-36
"Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial", Wiley, (2005), Vol 19, No 2: 148-151
"Does the addition of lamotrigine to risperidone improve psychotic symptoms and cognitive impairments in chronic schizophrenia?", OMICS Publishing Group, (2005), Vol 2, No 3: 399-406
"Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania", Elsevier BV, (2011), Vol 129, No 1-3: 327-331
"Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents", OMICS Publishing Group, (2005), Vol 2, No 4: 609-614
"Allopurinol as adjunctive treatment for acute mania in hospitalized bipolar patients", OMICS Publishing Group, (2005), Vol 2, No 5: 739-744
"Is there a relationship between estrogen serum level and symptom severity throughout the menstrual cycle of patients with schizophrenia?", OMICS Publishing Group, (2005), Vol 2, No 5: 745-751
"Topiramate prevents ecstasy consumption: a case report", Wiley, (2005), Vol 19, No 5: 601-602
"N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia", Ovid Technologies (Wolters Kluwer Health), (2013), Vol 36, No 6: 185-192
"Double-Blind, Placebo-Controlled Trial of Risperidone Plus Amantadine in Children With Autism", Ovid Technologies (Wolters Kluwer Health), (2013), Vol 36, No 6: 179-184
"Herbal medicine in the treatment of Alzheimer's disease", SAGE Publications, (2006), Vol 21, No 2: 113-118
"Comparing Effects of Ketamine and Thiopental Administration During Electroconvulsive Therapy in Patients With Major Depressive Disorder", Ovid Technologies (Wolters Kluwer Health), (2014), Vol 30, No 1: 15-21
"A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia", Springer Science and Business Media LLC, (2013), Vol 231, No 3: 533-542
"Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study", Wiley, (2013), Vol 15, No 6: 650-656
"Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: a randomized double-blind placebo-controlled study", The Society for Free Radical Research Japan, (2013), Vol 53, No 1: 36-40
"Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial", Springer Science and Business Media LLC, (2013), Vol 15, No 6: 505-514
"Total Antioxidant Capacity and Malondialdehyde in Depressive Rotational Shift Workers", Hindawi Limited, (2013), Vol 2013, No : 1-5
"Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia", Ovid Technologies (Wolters Kluwer Health), (2013), Vol 33, No 3: 336-342
"Saffron, Passionflower, Valerian and Sage for Mental Health", Elsevier BV, (2013), Vol 36, No 1: 85-91
"A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia", Springer Science and Business Media LLC, (2013), Vol 228, No 4: 595-602
"Cyproheptadine for Prevention of Neuropsychiatric Adverse Effects of Efavirenz: A Randomized Clinical Trial", Mary Ann Liebert Inc, (2013), Vol 27, No 3: 146-154
"Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia", Elsevier BV, (2006), Vol 84, No 2-3: 405-410
"Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study", Elsevier BV, (2013), Vol 47, No 4: 472-478
"Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial", Springer Science and Business Media LLC, (2012), Vol 20, No 1:
"Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study", Wiley, (2012), Vol 28, No 1: 54-60
"Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia", Springer Science and Business Media LLC, (2012), Vol 27, No 1: 57-65
"Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder", Physicians Postgraduate Press, Inc, (2012), Vol 73, No 11: 1428-1433
"Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study", Elsevier BV, (2013), Vol 47, No 2: 175-180
"Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial", Oxford University Press (OUP), (2013), Vol 16, No 4: 783-789
"Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression", Elsevier BV, (2013), Vol 38, No 6: 767-776
"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial", Wiley, (2006), Vol 8, No 5p1: 485-489
"Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder", Springer Science and Business Media LLC, (2012), Vol 26, No 10: 883-892
"Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial", Springer Science and Business Media LLC, (2012), Vol 225, No 1: 51-59
"Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: A double-blind, randomized and placebo-controlled trial", Elsevier BV, (2006), Vol 13, No 9-10: 607-611
"A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia", Springer Science and Business Media LLC, (2011), Vol 220, No 3: 591-598
"Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression", Wiley, (2011), Vol 28, No 4: 297-302
"Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial", Springer Science and Business Media LLC, (2011), Vol 42, No 3: 367-375
"Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial", Wiley, (2010), Vol , No : n/a-n/a
"The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial", Elsevier BV, (2010), Vol 116, No 2-3: 101-106
"PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL", Wiley, (2015), Vol 32, No 3: 167-173
"Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial", Springer Science and Business Media LLC, (2012), Vol 223, No 4: 381-388
"Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial", Springer Science and Business Media LLC, (2012), Vol 37, No 9: 2093-2100
"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study", Elsevier BV, (2012), Vol 141, No 2-3: 308-314
"A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders", Springer Science and Business Media LLC, (2012), Vol 43, No 5: 674-682
"Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial", Elsevier BV, (2010), Vol 34, No 1: 76-80
"A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia", Elsevier BV, (2008), Vol 32, No 3: 726-732
"Allopurinol as Adjunctive Therapy in Intractable Epilepsy: A Double-blind and Placebo-controlled Trial", Elsevier BV, (2007), Vol 38, No 3: 313-316
"Allopurinol as Adjunctive Therapy in Intractable Epilepsy: A Double-blind and Placebo-controlled Trial", Elsevier BV, (2007), Vol 38, No 3: 313-316
"Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches", Informa UK Limited, (2007), Vol 7, No 2: 195-201
"Antidepressant-like effect of magnetic resonance imaging-based stimulation in mice", Elsevier BV, (2007), Vol 31, No 2: 503-509
"Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial", Elsevier BV, (2007), Vol 31, No 2: 439-442
"Autism Spectrum Disorders: Etiology and Pharmacotherapy", Bentham Science Publishers Ltd., (2007), Vol 2, No 2: 97-103
"Prevalence of obsessive-compulsive disorder in Iran", Springer Science and Business Media LLC, (2004), Vol 4, No 1:
"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial", Wiley, (2009), Vol 26, No 7: 607-611
"Comparing the Effects of High-Dose Vitamin E With Those of Placebo on Insulin Resistance in Patients With Schizophrenia Treated With Olanzapine", Ovid Technologies (Wolters Kluwer Health), (2009), Vol 29, No 2: 182-183
"Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial", Elsevier BV, (2009), Vol 107, No 2-3: 206-212
"A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia", Elsevier BV, (2008), Vol 32, No 8: 1810-1815
"Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study", Elsevier BV, (2008), Vol 32, No 8: 1879-1883
"A Double-blind Placebo Controlled Trial of Piracetam Added to Risperidone in Patients with Autistic Disorder", Springer Science and Business Media LLC, (2007), Vol 39, No 3: 237-245
"Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study", Wiley, (2008), Vol 23, No 2: 79-86
"A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease", Springer Science and Business Media LLC, (2009), Vol 207, No 4: 637-643
"Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism", Elsevier BV, (2010), Vol 34, No 1: 32-36
"Combination of citalopram and nortriptyline in the treatment of severe major depression: a double-blind, placebo-controlled trial", OMICS Publishing Group, (2007), Vol 4, No 2: 187-192
"Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial", Elsevier BV, (2008), Vol 32, No 1: 145-149
"Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial", Elsevier BV, (2007), Vol 90, No 1-3: 179-185
"Tincture of opium for treating opioid dependence: a systematic review of safety and efficacy", Wiley, (2016), Vol 112, No 3: 415-429
"Role of Melatonin in Body Weight: A Systematic Review and Meta-Analysis", Bentham Science Publishers Ltd., (2017), Vol 23, No 23:
"A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism", Elsevier BV, (2015), Vol 229, No 1-2: 181-187
"<scp>l</scp>-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial", Mary Ann Liebert Inc, (2018), Vol 28, No 5: 331-338
"Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial", Mary Ann Liebert Inc, (2017), Vol 27, No 5: 440-444
"Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial", Wiley, (2019), Vol 73, No 11: 690-696
"Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial", Oxford University Press (OUP), (2020), Vol 23, No 12: 775-782
"A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania", Mary Ann Liebert Inc, (2017), Vol 27, No 6: 494-500
"Are Supplementation of Omega-3 and Ascorbic Acid Effective in Reducing Oxidative Stress and Depression among Depressed Shift Workers?", Hogrefe Publishing Group, (2015), Vol 85, No 5-6: 299-310
"Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial", Mary Ann Liebert Inc, (2016), Vol 26, No 9: 784-791
"The effect of saffron (Crocus sativus L.) hydroalcoholic extract on metabolic control in type 2 diabetes mellitus: A triple-blinded randomized clinical trial", Medknow, (2018), Vol 23, No 1: 16
"Influence of citicoline on citalopram-induced antidepressant activity in depressive-like symptoms in male mice", Elsevier BV, (2018), Vol 195, No : 151-157
"Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive–compulsive disorder: A double‐blind randomized trial with placebo control", Wiley, (2018), Vol 73, No 4: 169-174
"Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial", Mary Ann Liebert Inc, (2016), Vol 26, No 9: 784-791
"Fluticasone propionate in clinically suspected asthma patients with negative methacholine challenge test", Wiley, (2015), Vol 11, No 4: 433-439
"Contribution of health researches in national knowledge production: A scientometrics study on 15-year research products of Iran", Medknow, (2017), Vol 8, No 1: 27
"Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study", Wiley, (2017), Vol 32, No 4: e2583
"Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study", Wiley, (2016), Vol 70, No 8: 332-341
"Next generation sequencing: implications in personalized medicine and pharmacogenomics", Royal Society of Chemistry (RSC), (2016), Vol 12, No 6: 1818-1830
"Fluticasone propionate in clinically suspected asthma patients with negative methacholine challenge test", Wiley, (2015), Vol 11, No 4: 433-439
"Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double‐blind, placebo‐controlled trial", Wiley, (2019), Vol 45, No 1: 97-104
"The Requisiteness for not Sacrificing Medical Biotechnology in the Coronavirus Era", Knowledge E, (2021), Vol , No :
"Author’s Reply to the Letter to the Editor by Fountoulakis", Georg Thieme Verlag KG, (2017), Vol 51, No 03: 106-107
"Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients", SAGE Publications, (2015), Vol 49, No 9: 953-961
"Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial", Elsevier BV, (2015), Vol 183, No : 149-155
"Efficacy and safety of Sophora alopecuroides var. alopecuroides seed extract for opioid detoxification: A randomized, double‐blind, and placebo‐controlled clinical trial", Wiley, (2019), Vol 34, No 5: 1108-1113
"How the US Sanctions Are Affecting the Health Research System in Iran?", Maad Rayan Publishing Company, (2021), Vol 24, No 2: 101-106
"Basic Science and Clinical Studies on Non-COVID-19 Topics, of Coronavirus Victims", Knowledge E, (2020), Vol , No :
"Prospects of Saffron and its Derivatives in Alzheimer’s Disease", Maad Rayan Publishing Company, (2021), Vol 24, No 3: 233-252
"The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial", Elsevier BV, (2018), Vol 41, No : 196-202
"Infectious agents and different course of multiple sclerosis: a systematic review", Springer Science and Business Media LLC, (2018), Vol 118, No 3: 361-377
"Medicinal Plants in the Treatment of Obsessive-Compulsive Disorder: A Review", Bentham Science Publishers Ltd., (2021), Vol 18, No 1: 8-16
"Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double‐blind and placebo‐controlled randomized trial", Wiley, (2019), Vol 45, No 2: 324-334
"Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double‐blind, placebo‐controlled clinical trial", Wiley, (2020), Vol 74, No 7: 398-405
"The interplay between gut microbiota and autism spectrum disorders: A focus on immunological pathways", Elsevier BV, (2021), Vol 106, No : 110091
"The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial", Wiley, (2016), Vol 31, No 2: 103-112
"Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial", Wiley, (2015), Vol 17, No 6: 606-614
"Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial", Wiley, (2018), Vol 33, No 4: e2662
"Nutrients for Prevention and Treatment of Mental Health Disorders", Elsevier BV, (2013), Vol 36, No 1: 25-36
"Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]", Springer Science and Business Media LLC, (2004), Vol 4, No 1:
"Is transcranial direct current stimulation an effective modality in reducing food craving? A systematic review and meta-analysis", Informa UK Limited, (2018), Vol 23, No 1: 55-67
"Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial", Springer Science and Business Media LLC, (2019), Vol 28, No 12: 1619-1628
"Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial", Springer Science and Business Media LLC, (2018), Vol 297, No 3: 717-724
"Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study", Elsevier BV, (2014), Vol 215, No 3: 540-546
"More ACTIONS needed to reach a consensus on adjunctive antidepressant therapy for negative symptoms of schizophrenia", BMJ, (2016), Vol 20, No 1: e3-e3
"Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial", Wiley, (2016), Vol 70, No 11: 517-526
"Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders–a double-blind, randomized intervention study", Elsevier BV, (2019), Vol 282, No : 112613
"Possibility for science without borders in the Trump era", Elsevier BV, (2019), Vol 393, No 10170: 405-406
"Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial", SAGE Publications, (2020), Vol 34, No 5: 506-513
"A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder", Canadian Science Publishing, (2020), Vol 98, No 4: 236-242
"Correction: A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder", Canadian Science Publishing, (2020), Vol 98, No 6: 412-412
"Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial", Springer Science and Business Media LLC, (2020), Vol 30, No 5: 799-807
"Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: A double-blind randomized trial", Elsevier BV, (2020), Vol 18, No 5: 409-415
"Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial", Springer Science and Business Media LLC, (2020), Vol 52, No 5: 928-938
"Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial", Ovid Technologies (Wolters Kluwer Health), (2021), Vol 36, No 3: 140-146
"Efficacy of melatonin as an adjunct in the treatment of acute mania", Ovid Technologies (Wolters Kluwer Health), (2020), Vol 35, No 2: 81-88
"Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial", SAGE Publications, (2018), Vol 33, No 3: 305-315
"Vitamin E and ginseng supplementation to enhance female sexual function: a randomized, double-blind, placebo-controlled, clinical trial", Informa UK Limited, (2020), Vol 60, No 10: 1164-1173
"L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study", Wiley, (2017), Vol 32, No 4: e2584
"The role of phthalate esters in autism development: A systematic review", Elsevier BV, (2016), Vol 151, No : 493-504
"Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial", Elsevier BV, (2017), Vol 255, No : 59-65
"Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: A randomized, double-blind, placebo-controlled, clinical trial", Elsevier BV, (2014), Vol 24, No 6: 846-855
"Sudden hearing loss subsequent to diarrhea: what is the missing link?", Springer Science and Business Media LLC, (2014), Vol 22, No 1:
"A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression", Hindawi Limited, (2019), Vol 45, No 1: 134-143
"Omega-3 supplementation effects on body weight and depression among dieter women with co-morbidity of depression and obesity compared with the placebo: A randomized clinical trial", Elsevier BV, (2018), Vol 25, No : 37-43
"Effect of sweet almond syrup versus methylphenidate in children with ADHD: A randomized triple-blind clinical trial", Elsevier BV, (2019), Vol 36, No : 170-175
"Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial", Elsevier BV, (2018), Vol 235, No : 236-241
"Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial", Elsevier BV, (2018), Vol 232, No : 127-133
"L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial", Elsevier BV, (2018), Vol 262, No : 94-101
"A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients", Elsevier BV, (2014), Vol 155, No : 216-222
"l-lysine as an adjunct to risperidone in patients with chronic schizophrenia: A double-blind, placebo-controlled, randomized trial", Elsevier BV, (2014), Vol 59, No : 125-131
"Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial", Elsevier BV, (2016), Vol 75, No : 24-30
"Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial", Elsevier BV, (2016), Vol 204, No : 1-8
"Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial", Elsevier BV, (2017), Vol 94, No : 70-77
"Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial", Mary Ann Liebert Inc, (2018), Vol 28, No 1: 82-89
"Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial", Ovid Technologies (Wolters Kluwer Health), (2021), Vol 36, No 5: 238-243
"Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting: A randomized, double-blind, placebo-controlled trial", Elsevier BV, (2021), Vol 150, No : 110635
"Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production", Knowledge E, (2021), Vol , No :
"Efficacy and tolerability of Lavandula angustifolia in treating patients with the diagnosis of depression: a systematic review of randomized controlled trials", Walter de Gruyter GmbH, (2021), Vol 0, No 0:
"Iran’s scientists uncrushed by decades of sanctions", Springer Science and Business Media LLC, (2018), Vol 559, No 7714: 331-331
"Prednisolone as Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial", Ovid Technologies (Wolters Kluwer Health), (2020), Vol 43, No 2: 39-45
"Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?", Ovid Technologies (Wolters Kluwer Health), (2020), Vol 43, No 5: 139-145
"Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial", Ovid Technologies (Wolters Kluwer Health), (2019), Vol 42, No 6: 189-196

مقالات کنفرانسهای داخلی

اثرات ضد اضطرابی اسطوخودوس (Lavandula angustifolia ): مرور مطالعات نظام مند ارائه شده در اولین همایش ملی گیاهان دارویی، کارآفرینی و تجاری سازی (1400)

مقالات ژورنالهای تخصصی داخلی

Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial منتشر شده در مجله گیاهان دارویی ابن سینا (1401)
The neuropsychotropic effects of Crocus sativus L. (saffron): an overview of systematic reviews and meta-analyses investigating its clinical efficacy in psychiatric and neurological disorders منتشر شده در مجله گیاهان دارویی ابن سینا (1401)
Reliability and validity of the Persian version of Food Craving Questionnaire-Trait-Reduced (FCQ-T-r) in overweight and obese women منتشر شده در فصلنامه تغذیه، روزه داری و سلامت (1397)
بررسی فراوانی افسردگی و عوامل مرتبط با آن در نوبت کاران پالایشگاه نفت تهران منتشر شده در فصلنامه تحقیقات نظام سلامت (1392)
مقایسه اثر دارویی آمانتادین و متیل فنیدیت در کودکان و نوجوانان با اختلال نقص توجه/بیش فعالی: یک مطالعه کارآزمایی بالینی دو سو کور منتشر شده در فصلنامه ابن سینا (1390)
تعیین عناوین و محتوای برنامه های آموزش مداوم پزشکان عمومی در پنج موضوع منتخب: تطبیق نظر صاحب نظران و گروه هدف؛ تجربه دانشگاه علوم پزشکی تهران منتشر شده در مجله ایرانی آموزش در علوم پزشکی (1387)

طرح های تحقیقاتی و پژوهشی

خلاصه طرح پژوهشی یکپارچه سازی نظام های آموزشی در ایرانمرکز پژوهشهای مجلس(1390)
گزارش تفصیلی طرح پژوهشی یکپارچه سازی نظام های آموزشی در ایرانمرکز پژوهشهای مجلس(1390)

آقای دکتر شاهین آخوندزاده

Dr. Shahin Akhond Zadeh

استاد دانشگاه علوم پزشکی تهران